Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Giuliano

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
European Urology|October 5, 2013
Take a PAUSE for the premature ejaculation causeFrancois Giuliano
BJU International|March 2, 2006
Impact of medical treatments for benign prostatic hyperplasia on sexual functionFrancois Giuliano
The Journal of Sexual Medicine|February 6, 2017
Botox for Erectile DysfunctionFrancois Giuliano, Gerald Brock
The Journal of Sexual Medicine|April 13, 2013
Standard operating procedures for neurophysiologic assessment of male sexual dysfunctionFrancois Giuliano, David L Rowland
Toxins|May 24, 2019
Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport<sup>®</sup>) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction-Case StudiesFrancois Giuliano, Charles Joussain, Pierre Denys
Toxins|April 21, 2022
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin<sup>®</sup>) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case SeriesFrancois Giuliano, Pierre Denys, Charles Joussain
The Journal of Sexual Medicine|December 23, 2021
Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile DysfunctionFrancois Giuliano, Charles Joussain, Pierre Denys
European Urology|June 1, 2005
Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Raymond C Rosen, Francois Giuliano, Culley C Carson
Current Opinion in Urology|November 25, 2010
Botulinum neurotoxin A for male lower urinary tract symptomsEmmanuel Chartier-Kastler, Ulrich Mehnert, Pierre Denys, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2022
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for InnovationKarl-Erik Andersson, Delphine Behr-Roussel, Pierre Denys, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
European Urology|October 5, 2013
Take a PAUSE for the premature ejaculation causeFrancois Giuliano
BJU International|March 2, 2006
Impact of medical treatments for benign prostatic hyperplasia on sexual functionFrancois Giuliano
The Journal of Sexual Medicine|February 6, 2017
Botox for Erectile DysfunctionFrancois Giuliano, Gerald Brock
The Journal of Sexual Medicine|April 13, 2013
Standard operating procedures for neurophysiologic assessment of male sexual dysfunctionFrancois Giuliano, David L Rowland
Toxins|May 24, 2019
Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport<sup>®</sup>) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction-Case StudiesFrancois Giuliano, Charles Joussain, Pierre Denys
Toxins|April 21, 2022
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin<sup>®</sup>) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case SeriesFrancois Giuliano, Pierre Denys, Charles Joussain
The Journal of Sexual Medicine|December 23, 2021
Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile DysfunctionFrancois Giuliano, Charles Joussain, Pierre Denys
European Urology|June 1, 2005
Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Raymond C Rosen, Francois Giuliano, Culley C Carson
Current Opinion in Urology|November 25, 2010
Botulinum neurotoxin A for male lower urinary tract symptomsEmmanuel Chartier-Kastler, Ulrich Mehnert, Pierre Denys, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2022
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for InnovationKarl-Erik Andersson, Delphine Behr-Roussel, Pierre Denys, et al.
Pageof 5